Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

More than 12 million Americans suffer with sleep apnea, a potentially serious sleep disorder that causes your breathing to start and stop during rest and can lead to heart disease, stroke and diabetes ...

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat sleep apnea. It's taken before bedtime to help keep airways open during ...

Tens of millions of people in the United States struggle with obstructive sleep apnea, a condition that occurs when the throat muscles narrow during sleep, leading to temporary pauses in breathing ...

A new pill for sleep apnea could offer hope for those struggling with CPAP machines, according to leading researchers.

Sleep apnea, a condition affecting more than 12 million Americans, can lead to a host of health problems including heart disease. But, a new treatment containing ingredients derived from cannabis is ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, while effective, are often hindered by poor ...

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...